Molecular Pathology of Colorectal Cancer: Investigating the Role of Novel Molecular Profiles, microRNA's, and Their Targets in Colorectal Cancer Progression

University of Southampton1,000 enrolled

Overview

Molecular pathology of Colorectal Cancer: Investigating the role of novel molecular profiles, microRNA's and their targets in Colorectal Cancer progression

Single centre observational cohort study Prospectively recruited patients biomarker evaluation and identification of novel biomarkers

Study Type

OBSERVATIONAL

Enrollment

1,000

Conditions

Colorectal Cancer

Interventions

biomarker studyOTHER

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * colorectal cancer Exclusion Criteria: * hereditary CRC; tumours with extensive necrosis

Locations (1)

University Hospital Southampton

Southampton, United Kingdom

RECRUITING

Outcomes

Primary Outcomes

overall survival

Time frame: 5 years

disease free survival

Time frame: 5 years

local recurrence

Time frame: 5 years

distant recurrence

Time frame: 5 years

Central Contacts

Alex Mirnezami, MD PhD

CONTACT

ahm@soton.ac.uk

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.